Ninhydrin inhibition of glucose-induced insulin release
- PMID: 338407
- DOI: 10.1007/BF01236314
Ninhydrin inhibition of glucose-induced insulin release
Abstract
Ninhydrin, a compound which shares chemical properties strikingly similar to alloxan was found to mimic basically the inhibitory effect of alloxan on glucose-induced insulin release. Exposure of pancreatic islets for five minutes to 85 mumol/l ninhydrin produced approximately ninety percent inhibition of subsequent glucose-induced insulin release without altering basal secretion. Both D-glucose and D-mannose provided substantial protection against the inhibitory effect of ninhydrin, and the alpha anomer of D-glucose was more effective than the beta anomer in preventing ninhydrin inhibition of insulin release. Evidence for a common site of inhibition by ninhydrin and alloxan in the insulin release process is discussed.
Similar articles
-
Structural requirements of alloxan and ninhydrin for glucokinase inhibition and of glucose for protection against inhibition.Br J Pharmacol. 1988 Nov;95(3):851-9. doi: 10.1111/j.1476-5381.1988.tb11714.x. Br J Pharmacol. 1988. PMID: 3207996 Free PMC article.
-
Studies on the site of interaction for ninhydrin, alloxan, and D-glucose in insulin secretion by isolated islets in vitro.Endocrinology. 1979 Dec;105(6):1446-51. doi: 10.1210/endo-105-6-1446. Endocrinology. 1979. PMID: 387386 No abstract available.
-
Alloxan and ninhydrin inhibition of hexokinase from pancreatic islets and tumoural insulin-secreting cells.Pharmacol Toxicol. 1990 Mar;66(3):157-62. doi: 10.1111/j.1600-0773.1990.tb00725.x. Pharmacol Toxicol. 1990. PMID: 2185463
-
Molecular requirements for recognition at glucoreceptor for insulin release.Mol Pharmacol. 1979 Sep;16(2):361-8. Mol Pharmacol. 1979. PMID: 390361 No abstract available.
-
Metabolism of glucose and mannose anomers in pancreatic islets.Reprod Nutr Dev (1980). 1983;23(2 B):321-7. doi: 10.1051/rnd:19830301. Reprod Nutr Dev (1980). 1983. PMID: 6223355 Review.
Cited by
-
Structural requirements of alloxan and ninhydrin for glucokinase inhibition and of glucose for protection against inhibition.Br J Pharmacol. 1988 Nov;95(3):851-9. doi: 10.1111/j.1476-5381.1988.tb11714.x. Br J Pharmacol. 1988. PMID: 3207996 Free PMC article.